172 related articles for article (PubMed ID: 10844490)
21. Management of an anaphylactoid reaction to methotrexate with a stepwise graded challenge.
MacGinnitie AJ; Walensky LD; Turvey SE; Orange JS; Bonilla FA; Silverman LB; Oettgen H
Pediatr Allergy Immunol; 2003 Oct; 14(5):409-11. PubMed ID: 14641613
[TBL] [Abstract][Full Text] [Related]
22. Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria.
Ogawa Y; Ichinokawa Y; Hiruma M; Machida Y; Funakushi N; Sadamasa H; Hiruma M
J Dermatolog Treat; 2013 Dec; 24(6):463-5. PubMed ID: 23639034
[TBL] [Abstract][Full Text] [Related]
23. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria.
Wan KS; Chang YS
J Dermatolog Treat; 2014 Dec; 25(6):459-61. PubMed ID: 24192062
[TBL] [Abstract][Full Text] [Related]
25. Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.
Kim J; Ogai A; Nakatani S; Hashimura K; Kanzaki H; Komamura K; Asakura M; Asanuma H; Kitamura S; Tomoike H; Kitakaze M
J Am Coll Cardiol; 2006 Oct; 48(7):1378-84. PubMed ID: 17010798
[TBL] [Abstract][Full Text] [Related]
26. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
28. [Accelerated healing of ulcus ventriculi by a single evening dose of famotidine. Results of an Austrian-German-Italian multicenter study].
Dammann HG; Barbara L; Bianchi-Porro G; Cheli R; Hentschel E; Müller P; Paoluzzi P; Simon B; Walter TA
Schweiz Med Wochenschr; 1985 Apr; 115(14):484-8. PubMed ID: 2859653
[TBL] [Abstract][Full Text] [Related]
29. Histamine release during rapid vancomycin administration.
Renz C; Lynch J; Thurn J; Moss J
Inflamm Res; 1998; 47 Suppl 1():S69-70. PubMed ID: 9561421
[No Abstract] [Full Text] [Related]
30. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
31. Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study.
Paoluzi P; Torsoli A; Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Carratelli L; Cheli R
Digestion; 1985; 32 Suppl 1():38-44. PubMed ID: 2866135
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Ortonne JP; Grob JJ; Auquier P; Dreyfus I
Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
[TBL] [Abstract][Full Text] [Related]
34. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
35. The case of the horrible hives.
Eisenberg S
ONS Connect; 2011 May; 26(5):19. PubMed ID: 21675694
[No Abstract] [Full Text] [Related]
36. Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data.
Deutsch SI; Rosse RB; Kendrick KA; Fay-McCarthy M; Collins JP; Wyatt RJ
Clin Neuropharmacol; 1993 Dec; 16(6):518-24. PubMed ID: 9377587
[TBL] [Abstract][Full Text] [Related]
37. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
[TBL] [Abstract][Full Text] [Related]
38. [Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study].
Diller G; Orfanos CE
Z Hautkr; 1983 Jun; 58(11):785-93. PubMed ID: 6136132
[TBL] [Abstract][Full Text] [Related]
39. Combined H1 and H2 antihistamine therapy in chronic urticaria.
Monroe EW; Cohen SH; Kalbfleisch J; Schulz CI
Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
Vasil'ev IuV; Li IA
Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
